Molecular Partners AG
SIX:MOLN

Watchlist Manager
Molecular Partners AG Logo
Molecular Partners AG
SIX:MOLN
Watchlist
Price: 4.26 CHF -7.89%
Market Cap: 171.9m CHF
Have any thoughts about
Molecular Partners AG?
Write Note

Wall Street
Price Targets

MOLN Price Targets Summary
Molecular Partners AG

Wall Street analysts forecast MOLN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MOLN is 10.71 CHF with a low forecast of 6.06 CHF and a high forecast of 15.75 CHF.

Lowest
Price Target
6.06 CHF
42% Upside
Average
Price Target
10.71 CHF
151% Upside
Highest
Price Target
15.75 CHF
270% Upside
Molecular Partners AG Competitors:
Price Targets
397030
AprilBio Co Ltd
93% Upside
ADAG
Adagene Inc
350% Upside
OCX
OncoCyte Corp
92% Upside
600161
Beijing Tiantan Biological Products Corp Ltd
44% Upside
GBIO
Generation Bio Co
500% Upside
002252
Shanghai RAAS Blood Products Co Ltd
4% Downside
EXAS
Exact Sciences Corp
24% Upside
SWTX
SpringWorks Therapeutics Inc
94% Upside

Revenue
Forecast

Revenue Estimate
Molecular Partners AG

For the last 8 years the compound annual growth rate for Molecular Partners AG's revenue is -16%. The projected CAGR for the next 4 years is 83%.

-16%
Past Growth
83%
Estimated Growth
Estimates Accuracy
-26%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Molecular Partners AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
5%
Average Beat

Net Income
Forecast

Net Income Estimate
Molecular Partners AG

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-17%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MOLN's stock price target?
Price Target
10.71 CHF

According to Wall Street analysts, the average 1-year price target for MOLN is 10.71 CHF with a low forecast of 6.06 CHF and a high forecast of 15.75 CHF.

What is Molecular Partners AG's Revenue forecast?
Projected CAGR
83%

For the last 8 years the compound annual growth rate for Molecular Partners AG's revenue is -16%. The projected CAGR for the next 4 years is 83%.

Back to Top